Search | GSK

Corporate reporting 2014

First published: 05 June 2026

First published: 05 June 2026

GSK delivers 2014 core EPS of 95.4p (-1% CER excluding divestments) and dividend of 80 pence per share (+3%)

First published: 04 February 2015

GSK delivers Q2 2014 turnover £5.6 billion (-4%) and core EPS 19.1p (-12%) on ex-divestment basis (both CER). Q2 dividend 19p (+6%).

First published: 23 July 2014

GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 Discovery Fast Track Challenge.

First published: 25 February 2014

GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share

First published: 22 October 2014

Q1 turnover £5.6 billion, -2% (CER) on an ex-divestment* basis.

First published: 30 April 2014

The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.

First published: 17 November 2014

GSK announced the winners of its second Discovery Fast Track Challenge for academic researchers & drug discovery scientists at GSK

First published: 01 December 2014

First published: 01 June 2022